Existing experiments have shown that SOX5 is highly expressed in many malignant tumors, including prostate cancer, breast cancer, hepatocellular carcinoma, nasopharyngeal carcinoma and other malignant tumors (45–47). The gene discussed is SOX5; the disease is cancer.